Drug
Galiximab
Galiximab: highest development phase Phase 1, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Galiximab NCT00651443 | Phase 1 | Lymphoma, Non-Hodgkin's |
Latest
No recent events.
Follow Galiximab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.